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ABSTRACT OF THE THESIS 
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Research suggests that there is a significant impact of poverty on poor health 
outcomes. Poverty is associated with limited access to education and healthcare, 
increased exposure to violence, and chronic stress that contribute to the development of 
chronic diseases. The poverty and chronic disease relationship is potentially associated 
with chronically elevated stress biomarkers. The present study investigated the 
relationship between demographics, poverty (during childhood, young adulthood, and 
mid/late adulthood), allostatic load—a cumulative measure of system dysregulation—and 
the Charlson Comorbidity Index, a measure of chronic disease and mortality, using data 
from the Biopsychosocial and Religion and Health Study (BRHS; Lee et al., 2009) a 
subset of participants in the Adventist Health Study-2 cohort of Seventh-day Adventists. 
Of this subset 387 were examined on demographics, poverty, allostatic load (preclinical 
elevations in 13 biomarkers), chronic diseases and likelihood of mortality. Poverty 
experienced during childhood—but not during young adulthood or older adulthood—
predicted chronic disease severity in late life. Ethnicity moderates the child poverty and 
AL relationship such that Black individuals have higher risk of elevated stress markers 
than their White counterparts. Allostatic load has a stronger impact on comorbidity in 
younger individuals, suggesting a premature aging effect.  
1 
CHAPTER ONE 
INTRODUCTION 
Physiological Conceptualization of Stress 
Severe or chronic stress causes “wear and tear” on the physiological systems that 
accumulates over time; demands by the environment can create an imbalance in 
physiological systems (Wenzel, Glanz, & Lerman, 2002). This disruption may affect 
physical and/or psychological systems, requiring adaptational stress responses to 
reestablish balance. Typically, organisms cope with the demands through cognitive, 
affective and/or behavioral means and homeostasis is maintained. However, when 
demands outpace coping abilities, homeostasis is not maintained, functioning is impaired, 
and stress continues to disrupt systems.  When stress is experienced at chronic or extreme 
levels, functioning becomes impaired across multiple organ systems resulting in 
increased morbidity and mortality risk (Schneiderman, Ironson, & Siegel, 2005).  
Chronic stress is particularly taxing because it requires cognitive, affective and/or 
behavioral systems to continuously work to compensate for such demands.  Fatigue in 
these systems eventually leads to erosion in biological systems.  When biological stress 
regulation fails, chronic health conditions such as high blood pressure, heart disease, 
diabetes, asthma, arthritis, and depression may follow (Medline Plus, 2011).  With age, 
the risk of developing chronic disease or precursors to chronic disease increases. Chronic 
stress may cause premature aging and potentiate the risk of disease development. 
Prevalence of comorbid, chronic conditions in older adults escalates with 
advancing age.  Up to 45% of the general population and 88% of those over age 65 have 
at least one chronic health condition (Wolff, Starfield, & Anderson, 2002). About 57 
2 
million Americans currently have multiple, chronic conditions and it is estimated that this 
number will increase to 81 million by 2020 as the population ages, particularly with the 
“baby boomer” generation reaching late life. Ongoing research on the relationship 
between stress and effects on chronic disease prevalence and progression, and how to 
predict these conditions in preclinical biomarker elevations may further our 
understanding of the mechanisms linking chronic stressors to chronic disease and 
premature aging. 
The body’s automatic response to perceived stress involves the release of 
glucocorticoids and epinephrine (Tsigos & Chrousos, 2002). When acute stress is 
perceived, both the sympathetic nervous system (SNS) and the hypothalamic-pituitary-
adrenal (HPA) axis are activated. First, increased SNS activity triggers the secretion of 
epinephrine from the adrenal medulla.  Next, HPA activation triggers the secretion and 
transport of corticotropin-releasing hormone (CRH) to the anterior pituitary which then 
stimulates the secretion of the adrenocorticotropic hormone (ACTH) which enters 
circulating blood. ACTH, in turn, activates the adrenal cortex to release glucocorticoids 
into systemic circulation. Cortisol—the primary glucocorticoid stress hormone in 
humans—and sympathetic activation are involved in regulating and storing energy in 
organ systems to meet environmental demands. Removal of the acute stressor abates SNS 
activation. Additionally, when an acute stressor is no longer present, cortisol controls 
negative feedback effects to inhibit further activation of the hypothalamus and pituitary 
gland. The SNS is considered the “fight or flight” system triggered during times of acute 
arousal, vigilance, or perceived threat causing the sensation of an “adrenaline rush” 
commonly felt during high stress moments.  
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Chronic or repeated demands for the activation of these stress hormones may 
jeopardize healthy responses, causing organs to habituate to over- or under-respond to 
stressors (McEwen & Stellar, 1993). Neuroendocrine profiles that deviate from normal, 
healthy responses include: repeatedly activated, non-habituating, prolonged, and 
inadequate responses (McEwen, 2006). Over time, the chemical fluctuations cause 
system dysregulation in metabolic, inflammatory, and cardiovascular (CVS) biomarkers 
because of excessive activation. Short-term activation of the HPA axis is crucial for the 
acute stress response, however, chronic HPA activation results in unhealthy elevations of 
glucocorticoids, serum glucose, and lipid levels, immunosuppression, and increased 
cardiovascular tone, which are associated with biological aging and chronic diseases 
(Seeman et al., 1997). For example, excessive physiological activation may lead to 
tertiary health problems, such as cardiovascular diseases (i.e., strokes and heart attacks), 
metabolic syndromes (i.e., diabetes), and premature mortality (McEwen & Stellar, 1993).  
 
Allostatic Load 
McEwen’s (1998) Allostatic Load (AL) theory explains this link between chronic 
stress and poor health effects.  He posits that the excessive strain of repeated acute and/or 
chronic stressors has long-lasting effects on the stress-sensitive neuroendocrine, 
cardiovascular, immune, and neural systems. AL as such is a measure of preclinical 
elevations in biomarkers across these sensitive organ systems caused by over exposure to 
stressors, leading to chronic wear and tear and eventually disease (Seeman, Singer, Rowe, 
Horwitz, & McEwen, 1997). AL is a cumulative, multisystem measure of physiological 
dysregulation that may determine preclinical pathology and assess latent risk for 
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comorbidities before a disorder is overtly present (Karlamangla et al., 2002). Theories 
often explain biological systems as linear and rigid models of homeostasis that aim 
primarily to reduce fluctuations in the system to avoid negative health outcomes (Canon, 
1932). General systems theories look at each system individually instead of cumulatively 
and simultaneously. Over time, these general systems theories have shifted into more 
dynamic, nonlinear approaches, examining physiological systems as interactive with 
more fluctuations and less rigidity (Carlson & Chamberlain, 2005). The concept of 
allostasis and allostatic load emphasize this dynamic and nonlinear approach by 
measuring dysregulation in multiple adaptive systems as a collective. As such, allostatic 
load provides a life course, multi-system perspective of maladaptive physiological 
responses to stressors that may predict pathology before symptoms of disease overtly 
arise (Karlamangla et al., 2002).  
 
Measuring Allostatic Load 
AL provides a comprehensive summary of multiple biological system 
dysregulations that may result from excessive stress exposures and lead to premature 
aging. Seeman, McEwen, Rowe, and Singer (2001) developed a measure of AL that 
includes 10 parameters of biological functioning. Specifically, gathered blood and urine 
samples are used to determine functioning of the HPA axis, SNS (e.g., primary 
mediators), cardiovascular system, and metabolic processes (e.g., secondary 
mediators).  The biological parameters include (a) systolic and (b) diastolic blood 
pressure, (c) waist-to-hip ratio, (d) total cholesterol/high-density lipoprotein (HDL) ratio, 
(e) blood plasma levels of glycosylated hemoglobin (HbA1c), (f) urinary cortisol, (g) 
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urinary norepinephrine, (h) urinary epinephrine, (i) HDL cholesterol, and (j) 
dehydroepiandrosterone sulfate (DHEA-S).  Individuals are flagged as “high-risk” if they 
fall above or below the calculated threshold of either the upper or lower quartile 
(depending on the specific measure) of the sample on a standard distribution of collected 
biomarker data (Geronimus, 2006).  Individuals are allocated one point for each of the ten 
parameters in which they score at “high-risk.” Additionally, individuals taking medication 
for diabetes, hypertension, or high cholesterol are assigned one point for HbA1c, blood 
pressure, or total cholesterol, respectively, even if their current biomarker levels are not at 
the designated high-risk quartile, because an exisiting chronic disease diagnosis signals 
deterioration to the system has occurred though medications may control the biomarker 
levels.Higher scores indicate greater AL and risk for morbidity and mortality 
(Karlamangla, Singer, McEwen, Rowe, & Seeman, 2002). The HPA activation and 
elevated cortisol levels associated with AL predict a wide range of risk factors including 
obesity, hypertension, diabetes, hyperlipidemia, and accelerated brain aging with 
impaired cognitive and psychological functioning (Seeman, Singer, Rowe, Horwitz, & 
McEwen, 1997).  How AL is related to different stressors, such as poverty at different 
times of life is of potential interest.  Early stress exposure, for example, may damage the 
regulation systems and lead to cumulative damage. Chronic long-term stressors may be 
equally as damaging. 
 
Conceptualization of Poverty 
According to the National Center for Children in Poverty (2010), 19% of 
American children (14 million) live in financially impoverished families. From 2000 to 
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2008, child poverty increased by 21% and continues to rise. Wood (2003) defines poverty 
as an economic state that does not allow for adequate provision of basic family and child 
needs, such as sufficient food, clothing, and housing. The culture and debilitating 
conditions of poverty have a significant effect on child development and health (Evans, 
2004). Children born into poverty are at risk for developmental delay, learning disability, 
grade retention, expulsion or suspension, high school dropout, and young adult 
unemployment. Children living in poverty show significant deficits in several indices of 
cognitive and socioemotional development, including verbal memory, vocabulary, math 
and reading achievement, and a variety of behavioral problems (Korenman, Miller, & 
Sjaastad, 1995). Neurocognitive development is also compromised, particularly affecting 
brain regions (e.g., left perisylvian, medial temporal region, prefrontal cortex, anterior 
cingulate) that regulate working memory, cognitive control, language, and memory 
(Farah et al., 2006). In terms of physical health, compared to their peers, impoverished 
children are more likely to have poor to fair rather than excellent self-reported health. 
Impoverished children have higher rates of hospital admission, disability, and early 
mortality likely due to poor access to preventative, curative, and emergency medical care, 
while also having worse nutrition, parenting and housing, as well as higher exposure to 
harmful toxins like pollution (Evans, 2004).  As such, poverty often presents as a milieu 
of factors aside from insufficient basic needs being met (e.g., food, clothing, and 
housing). The negative effects of child poverty are often mediated by an accumulation of 
multiple environmental risks. These risks permeate relations within the home, including 
an increased exposure to family turmoil, violence, and separation in unstable and chaotic 
households (Evans, 2004). Children living in impoverished conditions have less social 
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support, less responsive parents, and experience more authoritarian parenting. They are 
also read to less often, watch more TV, and have less access to books and computers. 
Environmental risks also pervade their living conditions, including increased exposure to 
air and water pollution, and crowded, noisy, lower quality home conditions, as well as 
dangerous neighborhoods that offer fewer community and educational resources. Each 
psychosocial and physical risk factor of poverty has adverse developmental effects on 
children; exposure to such cumulative risks over time leads to physical, socioemotional, 
and cognitive morbidities in such children. Charmandari, Tsigos, and Chrousos (2005) 
suggest that childhood is a critical period and that children and adolescents, compared to 
adults, are more vulnerable to the physiological effects of stressors. 
These effects may be pervasive and likely have lasting effects into adulthood (Evans & 
Wachs, 2010). 
In a study on life course poverty, Rank and Hirschl (2001) found that a significant 
percentage of individuals will encounter poverty at some point in adulthood, particularly 
during early (ages 20-40) and later adulthood (ages 60-80). The prevalence of poverty in 
adulthood is related to race, education, and, to a lesser extent, gender. African Americans, 
individuals with less than 12 years of education, and women are more likely to 
experience poverty at some point in adulthood. Research on the effects of poverty in 
older adults suggests a significant social gradient in health, where socioeconomic status is 
linked to self-reported health status, physiological health, and psychological well-being 
(Marmot & Fuhrer, 2004). One theory is that poverty-related stress, influences an 
individual’s ability to cope and regulate physiological imbalances, leading to poorer 
physical health (Wadsworth, Raviv, Reinhard, Wolff, Santiago, & Einhorn, 2008). 
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Individuals who undergo chronic poverty (difficulty meeting expenses for basic needs for 
an extended period) are more vulnerable to negative health outcomes due to elevated 
HPA axis activation, which has been linked to several comorbid chronic diseases and 
deterioration of immune functioning (Taylor, Repetti, & Seeman, 1997). Victims of 
chronic stress tend to repetitively cycle through the three-phase syndrome of alarm, 
resistance, and exhaustion, which over time leads to cumulative damage to biological 
systems (Taylor, Repetti, & Seeman, 1997). McEwen and Stellar (1993) posit that chronic 
stressors can impair the body’s ability to meet these demands, creating allostatic load and 
cumulative damage. They argue that increases in stress leads to cumulative damage on 
the body that results in early morbidity and mortality.  Chronic poverty or poverty at 
certain developmental stages may create this type of chronic stress and subsequent 
physiological damage. 
Many studies have investigated the association between stress and health, 
(McEwen, 1993, 1998, 2007 & 2008, Schneiderman, Ironson, & Siegel, 2005, Glei, 
Goldman, Chuang, & Weinstein, 2007), but few have examined the mediating 
physiological pathways that link poverty to chronic disease. Additionally, researchers 
often examine the stress of poverty in association with individual biomarkers (i.e., 
perceived stress and cortisol levels, life challenges and epinephrine or norepinephrine 
levels, etc.). The current study examines the relationship between poverty in three 
different developmental periods, allostatic load that may become elevated earlier in life as 
a result of the chronic stress of poverty, and severity of chronic disease.  
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Hypotheses 
The purpose of the present study is to examine the relationship between a specific 
stressor (poverty) and elevated stress biomarkers of cumulative physiological 
dysregulation (AL) to predict comorbid conditions leading to a mortality risk score (CCI) 
in older adults. The study examines poverty at three-time points: childhood (under age 
18), young adulthood (age 18-35), and older adulthood (within the last year). The specific 
hypotheses to be tested are: 
(1)  After controlling for gender, ethnicity, age, and education 
a. Poverty during childhood will 
i. More strongly predict AL than poverty during young and 
middle/late adulthood. 
ii. more strongly predict chronic disease than poverty during young 
and middle/late adulthood. 
(2) Allostatic load will  
a. fully mediate the child poverty and chronic disease relationship. 
b. partially mediate the adult or recent poverty and chronic disease 
relationship. 
(3) Demographic factors such as gender and ethnicity will moderate the poverty and 
comorbidity relationship.  
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CHAPTER TWO 
METHOD 
Participants and Procedures 
This study will use data from the Biopsychosocial and Religion and Health Study 
(BRHS; Lee et al., 2009). Participants for the study were recruited from the Adventist 
Health Study-2 (AHS-2), a cohort study of lifestyle and cancer in 97,000 Seventh-day 
Adventists (SDAs) across North America in 2003-2006 (Butler et al., 2008). Of these, a 
random sample of about 21,000 were mailed a 20-page BRHS stress, religion and health 
survey and 10,988 returned usable surveys in 2006-2007.  Information on demographics, 
poverty, and physical comorbidities were gathered with the BRHS questionnaire. A 
subsample of 845 individuals who completed the survey and resided within a 60-mile 
radius of the campus was invited to also complete assessments on biometrics, biomarkers, 
and functional status in study clinics on campus or in a mobile clinic in Los Angeles. 
These assessments provided data for AL. Out of those invited, 622 were scheduled, 532 
came into the clinic, and 511 provided complete, usable data. The Institutional Review 
Board gave approval for the study as minimal risk and a written informed consent was 
given to all participants.  
Of these 511 a total of 124 were excluded from all analyses due to missing data or 
not meeting the study inclusion criteria of >50 years and Black or White ethnicity.  Thus, 
24 did not provide a blood sample, 16 did not provide a urine sample, 13 were missing 
poverty data, 5 were missing the Charlson Comorbidity Index data and 66 were under age 
50 or not Black or White.  This left 387 for the investigation.  These included were 
compared to the 124 excluded on demographics.  The participants included were similar 
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to those excluded on age, ethnicity, and education. however, those included were more 
likely to be male than those participants who were not included in the study. 
The final sample consisted of 153 males (39.5%) and 234 females (60.5%) with a 
mean age of 68.96 years (SD = 11.304). The sample was primarily White (59.9%), had 
some college or higher (92.6%), with little to no financial difficulty in the past year 
(92.2%) (see Table 1).  
Biological data was collected from participants who arrived at a scheduled 
morning appointment after fasting for 12 hours and completing both the AHS-2 and the 
BRHS questionnaires. An overnight urine sample was brought to the clinic where blood 
pressure, body measurements, and fasting blood samples were taken.  All clinical 
procedures, including assays of blood work and urine samples were conducted in the 
clinic or laboratory setting and all data coded in an SPSS V.23 database.  
 
Measures 
Demographic variables 
Participants provided information on age, race (Black or White), gender, and 
education (1-9 point scale; grade school to doctoral degree) using a self-report 
questionnaire. These variables were used as controls in the statistical analyses.  
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Table 1. Sample demographics and variables of interest (N=387). 
 N  % Mean SD 
Age  387  68.96 11.30 
Sex     
     Female 234 60.5   
     Male 153 39.5   
Ethnicity     
     White 232 59.9   
     Black 155 40.1   
Childhood Poverty   2.65  
     Not at all 103 26.6   
     A little 91 23.5   
     Somewhat 78 20.2   
     Fairly 67 17.3   
     Very 48 12.4   
Young Adulthood Poverty   1.99  
     Not at all 159 41.1   
     A little 125 32.3   
     Somewhat 60 15.5   
     Fairly 34 8.8   
     Very 9 2.3   
Mid/Late Adulthood Poverty (last 
year) 
  1.35  
     Not at all 317 81.9   
     A little 40 10.3   
     Somewhat 7 1.8   
     Fairly 12 3.1   
     Very 11 2.8   
Education (years completed)   6.86 1.676 
     Some High School 3 .8   
     High School Diploma 12 3.1   
     Trade School Diploma 10 2.6   
     Some College 74 19.3   
     Associate Degree 45 11.7   
     Bachelor’s Degree 83 21.6   
     Master’s Degree 81 21.1   
     Doctoral Degree 76 19.8   
 Mean SD Minimum Maximum 
Allostatic Load 3.6 2.00 0 10 
Charlson Comorbidity Index 3.11 1.67 1 11 
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Poverty 
Insufficient financial resources may cultivate feelings of instability, hopelessness, 
and anxiety that affect psychological and physiological functions. Poverty was measured 
with a self-report rating of “How difficult was it for you to meet expenses for basic needs 
(food, clothing, and housing) when you were <18 years, 18-35 years, and in the last 
year” on a 5-point rating scale (1 =Not at all to 5 =Very difficult; Pudrovska, Schieman, 
Pearlin, & Nguyen, 2005). Previous studies suggest that economic hardship is correlated 
with depression, physical distress, and lower self-reported health (Ross & Huber, 1985; 
Ross & Wu, 1995), as well as, morbidity and mortality (Pearlin et al., 1981). This item 
was modified to assess a retrospective report of poverty at three points across the lifespan 
in the present study. 
 
Allostatic Load (AL) 
The AL score was composed of 13 parameters that provide information on levels 
of physiological activity across a range of major physiological regulatory systems.  These 
included the hypothalamic-pituitary-adrenal (HPA), the sympathetic nervous, 
cardiovascular, and endocrine systems.  
The 13 parameters included: (a) waist-hip ratio (WHR; central adipose tissue 
deposition, metabolic-linked assessment for obesity), (b) systolic blood pressure (SBP) 
and (c) diastolic blood pressure (DBP) for cardiovascular function; (d) norepinephrine 
(NE) and (e) epinephrine (EPI) for sympathetic function, (f) cortisol and (g) DHEA-S for 
HPA function, (h) interleukin-6 (IL-6) and (i) C-reactive protein (CRP) measuring 
inflammatory mediators, (j) total cholesterol (TC), (k) HDL, and (l) TC to HDL ratio 
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measuring metabolic process and risk for  atherosclerosis, and (m) hemoglobin A1c 
(HbA1c; glycosylated hemoglobin identifies average glucose levels over the previous 3-
months for metabolic process, control of blood glucose levels, and risk for diabetes). The 
specific methods used to assess these parameters are detailed below. Each of the 13 
variables were divided into quartiles based on their individual distributions. Biomarkers 
that fell into the “highest risk” quartile (the top quartile for all parameters except for HDL 
cholesterol and DHEA-S for which ranking in the lowest quartile corresponds to the 
highest risk) were assigned one point. AL was calculated by summing the number of 
points accumulated across all 13 parameters. Therefore, the range for AL is 0 through 13. 
Individuals taking medication for diabetes or hypertension were allocated one point for 
HbA1c or blood pressure, respectively, to account for physiological damage to the 
metabolic or cardiovascular systems. The specific measures used for each of these 13 
parameters are as follows: 
1. Waist-Hip Ratio - WHR was calculated by waist circumference (mid-point 
between the lower ribs and upper margin of the iliac crest) divided by hip 
circumference (widest point around maximal buttocks) in inches. Waist 
and hip circumference was measured three separate times. An average was 
calculated from the three measurements for the final WHR used in 
analyses. WHR is a measure of abdominal fat accumulation; scores above 
0.9 or 0.85 for men and women, respectively, indicate obesity and are 
predictive of CVD and greater mortality risk in older adults (Price, Uauy, 
Breeze, Bulpitt, & Fletcher, 2006).  
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2-3. Blood Pressure – Systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) were assessed after a 10-minute resting period in a quiet 
room using an automated blood pressure monitor (an Omron blood 
pressure monitor) and different sized arm cuffs. SBP and DBP were 
measured three times and the data averaged, and expressed in mmHg. 
4-6. Twelve-hour Urine Samples. - Urine collection kits, including simple 
instructions for collection, were mailed to participants prior to their clinic 
appointment. Participants were instructed, after an initial void, to collect 
the urine sample in a container containing [preservative] the evening 
before their clinic visit between 7 p.m. to 7 a.m., store the container in a 
cool place, and bring the sample to their clinic visit. Participants were also 
instructed to avoid certain foods (ie: coffee, cocoa, tea, citrus fruits, 
bananas, vanilla, and chocolate) for several days, as they can raise 
catecholamine levels in the urine. Participants returned the filled urinary 
container, the urine volume was recorded, and 4 ml of urine were 
aliquoted into 4 4-ml cryovials per study participant. Samples were 
transported on ice across campus, logged into a database, and stored at -
80 °C until analyses. Urine samples were used to evaluate 12-hour urinary 
cortisol, norepinephrine and epinephrine levels. Data were normalized for 
volume by expressing the concentration of these variables by dividing the 
values by the concentration of urinary creatinine.  
a. Creatinine. Urinary creatinine levels were assessed by 
commercial enzyme-linked immunoassay (ELISA) kits (Metra, San 
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Diego, CA) after samples were centrifuged at low speed (200 x g) for 3 
minutes to remove debris, and then diluted 1:40 with distilled water. Plates 
containing samples run in duplicate were read on a plate reader at 490 nm, 
and values determined based on the standard curve of known 
concentrations of creatinine.  Standards ranged from 0 to 40 mmol/L. 
Intra- and inter-assay variability was 1.7% and 4.3%, respectively. 
b. Catecholamines. High physiologic blood levels of the 
catecholamines, norepinephrine (NE) and epinephrine (EPI), are 
associated with psychological or physical stressors. Serum catecholamine 
concentrations were measured by high-performance liquid 
chromatography with Coulechem detection. Values were determined from 
known concentrations of NE and EPI, and data expressed in ng/ml. 
  c. Cortisol. Cortisol was assessed in overnight 12-hour urine 
samples along with known standards with an ELISA kit (Enzo, 
Farmingdale, NY) run in duplicate, according manufacturer’s instructions. 
Sample values were determined using a plate reader set at an optical 
density of 450 nm immediately after the stop solution was added to each 
well. Samples with concentrations outside the range of the standard curve 
(0-10 µg/ml) were diluted and re-run. Kit sensitivity was 0.005 µg/ml. 
Intra-assay and inter-assay variability with the kits were ~8.1 and 9.9%, 
respectively.  
7-13. Fasting Blood Samples - Measures of DHEA-S, IL-6, CRP, TC, HDL, and 
HbA1c were obtained from serum samples collected before 10:00 a.m.  For 
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all ELISA kits, the assays were run with duplicate samples and standards 
on each plate, according to manufacturer’s instructions. 
a. Serum DHEA-S levels were assessed with enzyme-linked 
immunosorbent assay (ELISA) kits (ALPCO, Salem, NH) in the 
Department of Pathology and Human Anatomy.  Plates included standards, 
and samples and standards were run in duplicate using a plate reader. The 
intra- and inter-assay precision averaged 9.3% and 9.2%, respectively, and 
the sensitivity of the kit was 0.005 µg/ml. 
b. Inflammatory Markers –  IL-6 and CRP are major markers of 
inflammation that rise in blood during periods of chronic stress, which is 
linked to premature aging and accelerated risk of cardio-metabolic disease 
(Kiecolt-Glaser, 2003). Serum CRP and IL-6 levels were determined using 
high-sensitivity Quantikine ELISA kits were run according to 
manufacturer’s instructions (Alpco, Salem, NH and R&D Systems, 
Minneapolis, MN, respectively). For CRP, the samples were diluted 1:500, 
and the plates were read immediately after applying the stop solution on a 
plate reader set at 450 and 620 nm to correct for optic distortion in the 
plate. The range of detections was 1.9 to 150 ng/ml with the limit of 
detection at 0.124 ng/ml. Intra- and inter-assay variability was 6% and 
9.5%, respectively. For IL-6, samples were run neat. Standards ranged 
from 0 to 10 pg/ml. Plates were read on a plate set at 490 nm or 650 nm. 
Correction for optical imperfections in the plate was done by determining 
the difference in values between these wavelengths. Intra- and inter-assay 
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variability was 7.4% and 7.8%, respectively.  The minimal detectable level 
was 0.039 pg/ml. 
c. HDL and TC were assessed with the CLIA-waived Cholestech 
LDX Analyzer (San Diego, CA).  Whole blood was applied to a 
Cholestech LDX cassette, and the cassette placed into the analyzer to 
simultaneously measure HDL and TC, triglycerides and glucose. LDL 
cholesterol was determined by subtracting the HDL levels from TC. 
Quality control testing with standards were performed before each clinic 
to verify results within established ranges, before patient samples were 
tested. 
d. HbA1c was assessed with the Cholestech GDX Analyzer from 
frozen stored blood samples after thawing (Selvin, Coresh, Jordahl, 
Boland, & Steffes, 2005). A self-check with a standard was run before 
each sample. Next, sample was applied to the A1c test cartridge and the 
cartridge inserted into the analyzer for HbA1c assessment, according to 
manufacturer’s instructions. 
 
Charlson Comorbidity Index. 
The Charlson Comorbidity Index (CCI) measures the risk of mortality in a clinical 
population by classifying comorbid conditions that influence 1-year mortality risk. It has 
been adapted to fit a variety of needs and populations, including self-report 
questionnaires (de Groot, Beckerman, Lankhorst, & Bouter, 2003). The full index 
includes 19 medical conditions with varying weights (1-6) and a total score between 0-37 
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(Charlson, Pompei, Ales, & MacKenezie, 1987). Age is also a predictor of mortality. 
Individuals above age 50 are assigned 1 point, with an additional point for each decade 
above age 50. CCI is the sum of the condition weights; a higher score indicates higher 
disease risk for mortality.  
A modified version used in the study was composed of 14 self-reported diseases, 
weighted according to the strength of their association with mortality, as shown in Table 
2. Conditions were assigned as: 1 point (myocardial infarction (MI), congestive heart 
failure (CHF), angina, arrhythmia, peripheral vascular disease, cerebrovascular disease, 
hypertension, connective tissue disease, ulcer disease, diabetes), 2 points (tumors, 
leukemia, lymphoma), or 6 points (metastatic solid tumors) based on disease prognosis 
and severity ratings. The index used is modified from its original version and does not 
include dementia, chronic pulmonary disease, liver disease, hemiplegia, renal disease, or 
acquired immunodeficiency syndrome (AIDs). Higher scores indicate a higher prognostic 
burden of comorbid disease, and a higher likelihood of earlier mortality. Information on 
self-reported diseases was gathered through the BRHS 2006-2007 questionnaire. Table 1 
details the descriptive information of the variable.  
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Table 2. Charlson Comorbidity Conditions with Weights. 
Assigned 
Weights 
For Disease 
Condition 
1 Myocardial Infarction  
 Congestive Heart Failure  
 Angina 
 Arrhythmia  
 Peripheral Vascular Disease 
 Cerebrovascular Disease 
 Hypertension  
 Connective Tissue Disease 
 Ulcer Disease 
 Diabetes 
2 Tumors 
 Leukemia 
 Lymphoma 
6 Metastatic Solid Tumor 
Note. Age would be added to the comorbidity score for participants 
creating age-comorbidity variable. A risk point of 1 is added to the 
Charlson Index score for each decade over 40 years of age. 
Therefore, an age of 50 adds one point whereas an age of 70 adds 3 
points.  
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Abstract 
Objective: Poverty is a stressful experience associated with negative health 
outcomes such as chronic disease and mortality risk. The poverty and chronic disease 
relationship may be affected by chronically elevated stress biomarkers assessed as 
allostatic load. The present study investigates the relationship among life-course poverty, 
allostatic load, and the Charlson Comorbidity Index, a measure that predicts the one-year 
mortality for a patient who may have a range of comorbid conditions. 
Method: Biopsychosocial and Religion and Health Study (BRHS; Lee et al., 
2009) participants from the Adventist Health Study-2 cohort of Seventh-day Adventists 
were assessed; 387 were examined on poverty, chronic diseases, and allostatic load 
(preclinical elevations in 13 biomarkers).   
Results: The results suggest that age and ethnicity are associated with allostatic 
load, such that older age and being Black predict higher levels of allostatic load. Also, 
poverty experienced during childhood—but not during young adulthood or older 
adulthood—predicts chronic diseases. Age moderates the relationship between allostatic 
load and chronic disease; such that, participants who were in the lower age group were 
more affected by allostatic load compared to participants in the sample that were older in 
age.  
Discussion: The results highlight the detrimental effects of childhood poverty and 
allostatic load on the severity of chronic disease. Both independently predicted health 
outcomes but no mediation was demonstrated. Demographic factors moderated these 
effects. Therefore, childhood poverty likely has a milieu of factors, aside from elevated 
stress biomarkers, that lead to poor health.    
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Introduction 
In 2015, approximately 43.1 million people (13.5%) in the United States were 
living in poverty, 13.4 million were children under the age of 18. (U.S. Census Bureau, 
2016). The ruthless course of poverty adversely affects the lives of many. Poverty is 
defined as an economic state that does not allow for adequate provision of basic family 
and child needs, such as sufficient food, clothing, and housing (Wood, 2003). However, 
poverty includes more than just a lack of economic resources; it encompasses a milieu of 
disadvantages that can be extremely stressful. These stressful risk factors include, but are 
not limited to, increased exposure to community violence, family turmoil, crowding, 
noise, and other hazardous interactions (Evans & English, 2002). Impoverished children 
have higher rates of hospital admission, disability, and early mortality due to limited 
access to preventative, curative, and emergency medical care, while also having worse 
nutrition, parenting and housing, and higher exposure to harmful toxins (Evans, 2004).  
Individuals exposed to chronic stress experience deterioration in biological 
regulatory systems. While the body is designed to regulate and maintain homeostasis, 
chronic stress can disrupt optimal physiological functioning. Perceived stress triggers a 
series of neurochemical fluctuations that activate a variety of metabolic, inflammatory, 
and cardiovascular responses. Excessive activation of the biomarkers associated with 
these systems cause significant physiological “wear and tear” and lead to chronic health 
problems such as, asthma, cardiovascular diseases (i.e., strokes and myocardial 
infarctions), diabetes, gastrointestinal disorders, and cancer, viral infections, and 
autoimmunity (McEwen & Stellar, 1993). Individuals enduring chronic stressors are also 
at higher risk for age-related metabolic disorders, elevated inflammation levels and 
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cortisol secretion, and accelerated cognitive decline and cellular aging (Danese & 
McEwen, 2012). 
McEwen’s (1998) allostatic load (AL) theory describes the link between stress 
and the development of chronic disease.  He posits that the excessive strain of repeated 
acute and/or chronic stressors has long-lasting effects on the neuroendocrine, 
cardiovascular, immune, and neural systems. As such, AL, is a measure of the preclinical 
elevations in biomarkers across these sensitive organ systems caused by over exposure to 
stressors, leading to chronic wear and tear and eventually disease (Seeman, Singer, Rowe, 
Horwitz, & McEwen, 1997). An AL index is a cumulative, multisystem measure of 
physiological dysregulation that may determine preclinical pathology and assess latent 
risk for comorbidities (Karlamangla et al., 2002). AL measures dysregulation in multiple 
adaptive systems collectively, instead of examining individual systems, and provides a 
life course perspective of maladaptive physiological responses to stressors that may 
predict pathology before symptoms of disease overtly arise (Karlamangla et al., 2002). 
Though poverty is linked to chronic disease (Adler & Ostrove, 1999), we do not 
yet know whether poverty exposure at different points in the life course has differential 
effects on allostatic load or on chronic disease severity.  It is possible that only childhood 
poverty creates actual change in the stress reactivity and regulation systems to lead to 
elevations in allostatic load (AL) and disease severity.  As such, poverty exposures during 
young and late adulthood will be compared to poverty during childhood to examine 
health outcomes (allostatic load and chronic disease severity).  AL will be examined as a 
potential mediator of the child poverty to chronic disease relationship.  
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Method 
Biopsychosocial and Religion and Health Study (BRHS; Lee et al., 2009) data 
from the Adventist Health Study-2 (AHS-2) cohort of Seventh-day Adventists (Butler et 
al., 2008) included the 10,988 who responded to a mailed, 20-page survey that included 
assessments of demographics, poverty, and physical comorbidities. The primary study 
population of the AHS-2 cohort includes Blacks and Whites.  Of the survey respondents, 
845 who resided within a 60-mile radius of the campus were invited to complete 
assessments on biometrics and biomarkers in study clinics on campus or in a mobile 
clinic in Los Angeles. Of these, 511 provided usable data and 387 met study inclusion 
criteria of >50 years of age and either Black or White with no missing data on relevant 
variables. Those included and excluded were similar on age, ethnicity, and education; 
however, more males were included in the sample than excluded. Descriptive statistics 
for participants are presented in Table 1. 
 
Measures 
Control Variables 
Participants provided information on age, race (Black or White), gender, and 
education level (1 = Grade school, 2 = Some High school, 3 = High school diploma, 4 = 
Trade school diploma, 5 = Some college, 6 = Associate degree, 7 = Bachelor’s degree, 8 
= Master’s degree, 9 = Doctoral degree) on the BRHS questionnaire in 2006-7.  
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Poverty 
Poverty at three age periods was rated on a 5-point scale (1=Not at all to 5=very 
difficult) on three items: “How difficult was it for you to meet expenses for basic needs 
(food, clothing, and housing) when you were <18 years; 18-35 years; and in the last 
year”  (Pudrovska, Schieman, Pearlin, & Nguyen, 2005). 
 
Allostatic Load 
AL was created by first dividing each of 13 biomarkers into quartiles, then 
assigning a 1 to the “highest risk” quartile (top quartile on all but HDL cholesterol and 
DHEA-S which were the bottom quartile) and a 0 to the other quartiles and finally 
summing across these 13 dichotomized biomarkers (Table 3). This created an AL score 
that could range from 0 to 13. Individuals taking medication for diabetes or hypertension 
were allocated one point for HbA1c or blood pressure, respectively, to account for 
physiological damage to the metabolic or cardiovascular systems that may have been 
masked by the medications. The parameters used for AL calculation included waist-hip 
ratio (WHR; central adipose tissue deposition, metabolic-linked assessment for obesity), 
systolic and diastolic blood pressure (SBP and DBP, respectively assessed three times 
after a 15 minute rest period and averaged; cardiovascular function), catecholamine, 
norepinephrine (NE) and epinephrine from overnight urine samples (EPI; sympathetic 
function), cortisol and DHEA-S (HPA function), interleukin-6 and C-reactive protein (IL-
6  and CRP, respectively from fasting blood samples; inflammatory mediators), total 
cholesterol (TC), HDL, and TC to HDL ratio from fasting blood samples (metabolic 
process; risk for  atherosclerosis), and hemoglobin A1c (HbA1c, glycosylated 
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hemoglobin from fasting blood samples to assess average 3 month glucose levels; 
metabolic process). See Table 4 for description of equipment used to measure parameters.  
 
  
2
8
 
 
Table 3. Allostatic Load Biomarker Quartile Parameter. 
 Biomarker Cut-Off score Normative Range Sample Mean 
Highest  Systolic Blood Pressure 138.0 mmHg 90-120 mmHg 126.23 mmHg 
 
Diastolic Blood Pressure 79.67 mmHg 
60-80 mmHg 72.94 mmHg 
 
Waist/Hip Ratio 0.96 
< 0.80 (women); <.90 
(men) 
0.88  
 
Norepinephrine 
61.20 mg/gm 
creatinine 
0 to 600 pg/mL 52.18 mg/gm creatinine 
 
Epinephrine 
7.78 mg/gm 
creatinine 
0 to 900 pg/mL 7.38 mg/gm creatinine 
 
Cortisol 
67.92 mg/gm 
creatinine 
10 to 20 µg/dl (morning) 57.38 mg/gm creatinine 
 Interleukin-6 5.64 pg/ml   6.00 pg/ml 
 C-Reactive Protein 2336.76 mg/L <30 mg/L 2239.6232 mg/L 
 Total Cholesterol (TC) 208 mg/dL <200 mg/dL 117.15 mg/dL 
 TC/HDL ratio 4.8 -- 3.90 
 
Glycosylated Hemoglobin 6.3% 
4% to 5.6% 5.9% 
Lowest  HDL 38 mg/dL >60 mg/dL 46.92 mg/dL 
 
DHEA-S 0.82 µg/ml 
0.13 to 1.3 µg/ml 
(female, age 60-69); 0.42 
to 2.9 µg/ml (male, age 
60-69) 
0.69 µg/ml 
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Table 4. Allostatic Load Biomarker measurements.  
Allostatic Load Biomarker Method/Equipment Used 
 Waist-Hip Ratio Waist circumference divided by hip 
circumference in inches. Measured 3 
times and averaged for final WHR. 
 Systolic Blood Pressure, Diastolic 
Blood Pressure 
Automated blood pressure monitor 
(Omron) 
 Creatinine, Catecholamine 
(Norepinephrine & Epinephrine), 
Cortisol 
ELISA kits used to measure urine 
samples 
 DHEA-S, IL-6, CRP ELISA kits used to measure fasting 
blood samples 
 TC, HDL, and HbA1c Cholestech LDX Analyzer 
 
 
 
Charlson Comorbidity Index (CCI) 
CCI was composed from 14 diseases assessed on the BRHS 2006-2007 
questionnaire. Conditions were weighted according to the strength of their association 
with mortality risk, as shown in Table 2. Conditions were assigned as: 1 point 
(myocardial infarction (MI), congestive heart failure (CHF), angina, arrhythmia, 
peripheral vascular disease, cerebrovascular disease, hypertension, connective tissue 
disease, ulcer disease, diabetes), 2 points (tumors, leukemia, lymphoma), or 6 points 
(metastatic solid tumors) based on disease prognosis and severity ratings. The index used 
is modified from its original version and does not include dementia, chronic pulmonary 
disease, liver disease, hemiplegia, renal disease, or acquired immunodeficiency syndrome 
(AIDs) as these had not been included in the BRHS questionnaire. Higher scores indicate 
a higher prognostic burden of comorbid disease, and a higher likelihood of earlier 
mortality (Charlson, Pompei, Ales, & MacKenezie, 1987).  
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Results 
Assumptions for normality, homoscedasticity, linearity, and multicollinearity were 
met. A hierarchical linear regression was performed to examine the effects of poverty on 
AL, after controls (Table 5). Variables were entered in the following blocks: (a) 
demographics (gender, education, ethnicity, age), gender and ethnicity were dummy 
coded, with females and Whites as the reference group, (b) childhood poverty, (c) young 
adulthood poverty, and (e) mid/late adulthood poverty, (f) ethnicity x child poverty, (g) 
age x child poverty. The regression model accounted for a small, but statistically 
significant proportion of the variance in AL, R2 = .084, F(9, 383) = 4.898, p < .001 (Table 
5). Ethnicity and age were positively associated with AL, such that as age increased by 
one year, AL increased by .048 points after controls p < .0001, CI [.029, .067]. Subjects 
who were Black, on average, had an increase of .859 points in AL, compared to White 
subjects, after controls p < .0001, CI [.416, 1.302]. None of the three poverty exposures 
independently predicted AL after controls.  
 
Table 5. Regression of Lifetime Poverty on AL 
  b SE β t p 
Gender (-1 = female, 1 = male) 0.061 0.215 0.015 0.284 0.776 
Ethnicity (-1 = white, 1 = black) 0.859 0.225 0.209 3.816 0.000** 
Education -0.111 0.068 -0.093 -1.648 0.100 
Age 0.048 0.009 0.269 5.071 0.000** 
    Child Poverty 0.048 0.083 0.032 0.576 0.565 
Young Adulthood Poverty 0.027 0.108 0.014 0.252 0.801 
Mid/Late Adulthood Poverty -0.051 0.123 -0.022 -0.409 0.683 
Ethnicity x Child Poverty 0.005 0.079 0.003 0.062 0.951 
Age x Child Poverty 0.003 0.007 0.020 0.385 0.700 
Note. * p < .05, **p < .001, two-tailed. 
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A hierarchical linear regression was performed to examine whether poverty and 
AL predicted CCI, after controls. Variables were entered in the following blocks: (a) 
demographics (gender, education, ethnicity, age), gender and ethnicity were dummy 
coded, with females and Whites as the reference group, (b) childhood poverty, (c) young 
adult poverty, and (d) mid/late adulthood poverty, and (e) AL, (f) gender x AL, (g) 
ethnicity x AL, (h) age x AL, (i) child poverty x AL. The regression model accounted for 
a significant proportion of the variance in CCI, R2 = .707, F(12, 383) = 74.576, p < .001 
(see Table 6). Age, child poverty, and AL significantly predicted CCI. The results also 
suggest a significant interaction between age and  AL on CCI, β = -.107, t = -3.519, p 
< .001. We we examined this further, results showed that for those in the lower age group 
(one standard deviation below the mean), each additional AL point results in a .066 unit 
increase in CCI, b = .0657, t(df) = 5.3762(374), p < .0001, CI [.0416, .0897]. For those in 
the mean age group, each additional AL point results in a .034 unit increase in CCI, b 
= .0342, t(df) = 3.8961(374), p < .001, CI [.0169, .0515]. And, for those in the higher age 
group (one standard deviation above the mean age), each additional AL point results an 
insignificant .003 unit increase in CCI, p > .05. This interaction indicates that AL has 
very little impact on chronic disease severity in older individuals, but a significantly 
greater impact on chronic disease severity for individuals younger in age, which is 
suggestive of a premature aging effect (Figure 1). 
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Table 6. Regression of Lifetime Poverty and AL on CCI 
 
 b SE β t p 
Gender (-1 = female, 1 = male) -0.003 0.018 -0.005 -0.167 0.868 
Ethnicity (-1 = white, 1 = black) 0.019 0.02 0.032 0.983 0.326 
Education -0.015 0.012 -0.043 -1.322 0.187 
Age 0.0420 0.002 0.790 25.143 0.000** 
    Child Poverty 0.040 0.014 0.091 2.835 0.005* 
Young Adulthood Poverty -0.022 0.018 -0.04 -1.205 0.229 
Mid/Late Adulthood Poverty -0.005 0.021 -0.007 -0.237 0.813 
    Allostatic Load 0.034 0.009 0.115 3.843 0.000** 
    Gender x AL -0.008 0.018 -0.013 -0.445 0.656 
    Ethnicity x AL -0.015 0.019 -0.024 -0.771 0.441 
    Age x AL -0.003 0.001 -0.107 -3.343 0.001* 
    Child Poverty x AL -0.001 0.007 -0.004 -0.139 0.89 
Note. * p < .05, **p < .001, two-tailed.     
 
 
 
Figure 1. Relation between elevated stress biomarkers (allostatic load) and chronic disease 
(Charlson Comorbidity Index) for three different age groups (low, average, high). 
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A mediation model was tested using the SPSS PROCESS Macro (Hayes, 2012) to 
examine whether AL mediates the relationship between poverty and chronic disease. The 
results of the model suggest that AL does not mediate the relationship between poverty 
(childhood, young adulthood, or mid/late adulthood) and chronic disease, b = .0281, SE 
= .0184, 95% CI = -.0064, .0670.  
 
 
Discussion 
The current study examined the effects of life-course poverty on health in older 
Blacks and Whites via elevated chronic stress biomarkers indicating premature aging. 
Ample research supports that poverty in early childhood can leave lasting, devastating 
effects on stress regulating systems and that this dysregulation is the principle underlying 
mechanism for early morbidity and mortality (Evans & Kim, 2007; McEwen, 1998, 
2000). The results contribute to and support this growing body of literature, further 
showing that poverty experienced at younger ages has a stronger effect on morbidity than 
poverty experienced as an adult. However, these results should be interpreted with 
caution and may be inconclusive due to the limited number of individuals in the sample 
who have experienced adulthood poverty. Further, the Charlson Comorbidity index used 
to measure morbidity in the study is a modified version of the full index. Therefore, we 
are limiting the amount of variability captured by this index because several diseases 
were not included in the version used in the analysis.  
Literature on the use of AL as a measure of cumulative biological system 
dysregulation has grown in popularity due to its dynamic, flexible approach to 
measurement (Seeman et al., 1997, 2001, 2004; Gruenewald, 2012; Karlamangla, 2002). 
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AL, an indicator of elevated stress hormones and measure of cumulative physiological 
damage, is also associated with chronic disease severity. The results of the current study 
support existing literature on AL as a reliable prognosticator of morbidity risk.  
Ethnicity was found to be a demographic factor that significantly influenced AL. 
The study suggests that Black subjects generally had higher levels of AL compared to 
White subjects. Previous studies have suggested that racial/ethnic differences in AL can 
be explained by chronic social stressors, such as discrimination (Geronimus et al., 2006). 
This weathering effect posits that being Black is associated with higher levels of physical 
health deterioration, outside of the added stressor of poverty.  
The study also identifies age as a significant moderator of allostatic load for 
chronic disease severity. The interaction suggests that allostatic load has a greater effect 
on younger individuals, those whose biological systems have been less compromised by 
the effects of age. Conversely, older individuals who have already endured some 
physiological wear and tear from the normal aging process, experience less 
compromising effects of allostatic load on chronic disease severity although AL has a 
negative association with comorbidity regardless of age (see Figure 1). We were 
concerned for individuals born during the Great Depression era as a confounding factor 
for the effects found. However, individuals born during this time period did not comprise 
a significant proportion of the sample (20.7%).   
The increasing prevalence of chronic disease is a major area of concern for the 
healthcare economy. Center for Disease Control and Prevention (2009) estimates that 
75% of health care expenditures go toward treatment of chronic disease. Several factors 
that lead to chronic disease are preventable and/or manageable, therefore, it is important 
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for researchers to acknowledge the predictors and preclinical indicators that are present 
before full-blown manifestation of the chronic disease occurs.  
 
Strengths and Limitations and Future Directions 
The strengths of this study are the large sample size and the validated measures 
used to measure poverty at different age periods, AL, and chronic disease. The use of 
biomarkers to calculate AL offers a quantitative measure of cumulative stress-related 
physiological deterioration that reduces bias or subjectivity in self-reports. In addition, 
the demographics of the sample (highly educated, relatively healthy, affluent older adults) 
suggest findings of poverty, AL, and chronic disease on this unique population of 
Seventh-day Adventists likely underestimate the effects in a general population of the 
U.S. One of the limitations to our findings is the cross-sectional and retrospective self-
report measure of poverty and chronic illness. Generalizability of the findings is limited 
to those of similar socioeconomic status in the United States. Another limitation of the  
study is the restriction of range seen in our variables of interest. Table 1 displays 
the ranges of poverty, AL, and CCI which reflect a sample where the majority of 
participants, on average, have not experienced significant poverty and are relatively 
healthy. Future studies should aim to increase generalizability by sampling individuals 
across the spectrum of age, SES, education, and ethnicity to provide results more 
representative to the general U.S. population.     
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